Anastasia R Kovrizhina

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 12

Top Topics

Inflammatory Response

Endoplasmic Reticulum Stress

Top Venues

Xenobiotica; the fate of foreign compounds in biological systems

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Galina A Frelikh, Elena A Yanovskaya, Alexander P Lakeev, Galina A Chernysheva, Vera I Smolyakova, Anastasia R Kovrizhina
Dose proportionality and bioavailability of quinoxaline-based JNK inhibitor after single oral and intravenous administration in rats. Xenobiotica; the fate of foreign compounds in biological systems 54 (1) (2024)
Galina A Frelikh, Elena A Yanovskaya, Alexander P Lakeev, Galina A Chernysheva, Vera I Smolyakova, Anastasia R Kovrizhina
Dose proportionality and bioavailability of quinoxaline-based JNK inhibitor after single oral and intravenous administration in rats. Xenobiotica; the fate of foreign compounds in biological systems 54 (1) (2024)
Viacheslav V Andrianov, Igor A Schepetkin, Leah V Bazan, Khalil L Gainutdinov, Anastasia R Kovrizhina, Dmitriy N Atochin, Andrei I Khlebnikov
Evaluation of Nitric Oxide-Donating Properties of 11 H -indeno[1,2- b ]quinoxalin-11-one Oxime (IQ-1) by Electron Paramagnetic Resonance Spectroscopy. Molecules (Basel, Switzerland) 29 (16) (2024)
Igor A Schepetkin, Oleksander S Karpenko, Anastasia R Kovrizhina, Liliya N Kirpotina, Andrei I Khlebnikov, Stepan I Chekal, Alevtyna V Radudik, Maryna O Shybinska, Mark T Quinn
Novel Tryptanthrin Derivatives with Selectivity as c -Jun N-Terminal Kinase (JNK) 3 Inhibitors. Molecules (Basel, Switzerland) 28 (12) (2023)
Igor A Schepetkin, Oleksander S Karpenko, Anastasia R Kovrizhina, Liliya N Kirpotina, Andrei I Khlebnikov, Stepan I Chekal, Alevtyna V Radudik, Maryna O Shybinska, Mark T Quinn
Novel Tryptanthrin Derivatives with Selectivity as c -Jun N-Terminal Kinase (JNK) 3 Inhibitors. Molecules (Basel, Switzerland) 28 (12) (2023)
Igor A Schepetkin, Oleksander S Karpenko, Anastasia R Kovrizhina, Liliya N Kirpotina, Andrei I Khlebnikov, Stepan I Chekal, Alevtyna V Radudik, Maryna O Shybinska, Mark T Quinn
Novel Tryptanthrin Derivatives with Selectivity as c -Jun N-Terminal Kinase (JNK) 3 Inhibitors. Molecules (Basel, Switzerland) 28 (12) (2023)
Alexander P Lakeev, Galina A Frelikh, Elena A Yanovskaya, Anastasia R Kovrizhina, Vladimir V Udut
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC-MS/MS. Bioanalysis (2023)
Mark B Plotnikov, Galina A Chernysheva, Vera I Smol'yakova, Oleg I Aliev, Anna M Anishchenko, Olga A Ulyakhina, Eugene S Trofimova, Anastasia A Ligacheva, Nina D Anfinogenova, Anton N Osipenko, Anastasia R Kovrizhina, Andrei I Khlebnikov, Igor A Schepetkin, Anastasia G Drozd, Evgenii V Plotnikov, Dmitriy N Atochin, Mark T Quinn
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia. Pharmaceuticals (Basel, Switzerland) 16 (8) (2023)
Alexander P Lakeev, Galina A Frelikh, Elena A Yanovskaya, Anastasia R Kovrizhina, Vladimir V Udut
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC-MS/MS. Bioanalysis 14 (22) (2023)
Galina A Frelikh, Elena A Yanovskaya, Alexander P Lakeev, Galina A Chernysheva, Vera I Smolyakova, Anastasia R Kovrizhina
Dose proportionality and bioavailability of quinoxaline-based JNK inhibitor after single oral and intravenous administration in rats. Xenobiotica; the fate of foreign compounds in biological systems (2023)
Alexander P Lakeev, Galina A Frelikh, Elena A Yanovskaya, Anastasia R Kovrizhina, Vladimir V Udut
Quantification of a promising JNK inhibitor and nitrovasodilator IQ-1 and its major metabolite in rat plasma by LC-MS/MS. Bioanalysis 14 (22) (2023)
Galina A Frelikh, Elena A Yanovskaya, Alexander P Lakeev, Galina A Chernysheva, Vera I Smolyakova, Anastasia R Kovrizhina
Dose proportionality and bioavailability of quinoxaline-based JNK inhibitor after single oral and intravenous administration in rats. Xenobiotica; the fate of foreign compounds in biological systems (2023)